Intrinsic Value of S&P & Nasdaq Contact Us

Arbutus Biopharma Corporation ABUS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.50
+95.4%

Arbutus Biopharma Corporation (ABUS) has 5 identified peers for comparison in the Healthcare sector. Peers include ADAP, ADMA, AFMD, CRVS, VBIV.

ABUS has a market capitalization of $850.33M, compared to an average peer market cap of $771.84M.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message